CD226 and cancer: Analysis of DNAM-1 MFI in CD34+DNAM-1brightCXCR4+ cells (Figure 3A) showed a higher mean DNAM-1 density in peripheral blood vs. cancer-tissue precursors (p=0.03; Figure 3B).